Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Hepion Pharmaceuticals Inc (QB)
HEPA
Healthcare
Biotechnology
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical...
experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, HDV, and HIV-1. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCQB:HEPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(695)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 25, 2025 1:00pm
RE:RE:HEPA....bot the dip ; )
Well I'll be.....somebody actually replied to my post!!!!! Thank you mtgfree1 I'm kind of surprised that u of all people would comment on a U.S listed Co....just looking at alot of your
...more
(81)
•••
mtgfree1
X
Comment by
mtgfree1
on Mar 25, 2025 10:04am
RE:HEPA....bot the dip ; )
I do not see any value in this one, it could end up at 0.01-0.04 in my view , reverse split shows how diluted shares can get more PP now . Expect dilution again.
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 25, 2025 9:54am
HEPA....bot the dip ; )
60 pesos Cheers !!!!
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 21, 2025 11:13am
HEPA.....I will be back ; )
Will add on weakness
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 21, 2025 11:10am
HEPA....bot the dip and sold the rip ; )
Thanks
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 21, 2025 10:28am
HEPA....all over the map this a.m
BTFD's in my humble opinion
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2025 3:59pm
HEPA.....N.H.O.D $0.84
LFG!!!! AH over a buck?? Maybe
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2025 3:56pm
HEPA....I'd call that a Red to Green move
it started 20 mins before the close It might have seen it's bottom Going to have to move past a buck to be NASDAQ compliant....time will tell
(695)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2025 10:33am
HEPA.....Post RS and still non-compliant
This is an accident waiting to happen Lots of pre-funded warrants to drive the sh price down What a joke But ya have to put it on watch because it could just reverse the downtrend on a swipe of a
...more
(82)
•••
Finalrep
X
Post by
Finalrep
on Nov 29, 2021 11:20pm
Loading
Great time to buy this stock currently 1.22 what a steal.
(15)
•••
HDavis
X
Post by
HDavis
on Sep 13, 2021 2:44pm
HEPA - Major Buy Alert Update
(15)
•••
HDavis
X
Post by
HDavis
on Sep 12, 2021 11:51pm
HEPA - Major Buy Alert
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Vertical integration could reshape this scaling beverage brand’s long-term outlook
A transformational year in 2025 and positive outlook for growth in revenue and profitability in 2026
A custom portable drill advancing exploration in Labrador
A clean tech company on the verge of transformational growth plans to uplist to major US exchange
Podcasts